Preferred Label : Vivaglobin;

MeSH note : derived from human plasma; administered subcutaneously to prevent serious infections in patients with primary immune deficiency diseases (PIDD);

Is substance : O;

Details


Main resources

You can consult :


http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64513332
2012
France
summary of product characteristics
package leaflet
administration, cutaneous
Vivaglobin
Vivaglobin
injections, subcutaneous

---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14109a-fra.php
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14668a-fra.php
2011
Canada
French
English
Vivaglobin
immunoglobulins
injections, subcutaneous
immunoglobulins, normal human, for extravascular adm.
venous thrombosis
leg
stroke
pulmonary embolism
adult
child
thromboembolism
immunoglobulins
Product containing human immunoglobulin (medicinal product)
pharmacovigilance note
patient education handout

---
http://www.has-sante.fr/portail/display.jsp?id=c_400685
2005
France
evaluation of the transparency committee
administration, cutaneous
injections, subcutaneous
Vivaglobin
Vivaglobin

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.